{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:04:31Z","timestamp":1765814671466,"version":"3.48.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Anti-NMDAR encephalitis is the most prevalent form of autoimmune encephalitis, and status dystonicus may occur during the acute phase. Status dystonicus is a severe and rare acute movement disorder characterized by clinical manifestations resembling those of status epilepticus. However, there are currently limited case reports regarding anti-NMDAR encephalitis complicated by status dystonicus in pediatric patients. In this study, a pediatric patient with severe anti-NMDAR encephalitis developed status dystonicus during the acute phase. Symptoms gradually resolved following continuous intravenous infusion of midazolam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient was admitted to our hospital for detailed evaluation due to abnormal emotions, involuntary movements, and language impairment. Following admission, the patient developed seizures, impaired consciousness, cognitive dysfunction, and status dystonicus. Abnormal results were found in the electroencephalogram and cerebrospinal fluid tests, and the anti-NMDAR antibody was positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The child was diagnosed with severe anti-N-methyl-D-aspartate receptor encephalitis, presenting primarily with state dystonicus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The child received immunotherapy including immunoglobulin, methylprednisolone pulse therapy, and rituximab. When status dystonicus occurred, continuous intravenous infusion of midazolam was administered, resulting in resolution of the symptom.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Electroencephalography can effectively differentiate status dystonicus from status epileptic.Continuous intravenous infusion of midazolam can alleviate status dystonicus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>During the acute phase of anti-NMDAR encephalitis, pediatric patients may develop status dystonicus. Neurologists should promptly distinguish it from status epilepticus and implement appropriate management strategies to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046361","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:53Z","timestamp":1765814453000},"page":"e46361","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Severe anti-NMDA receptor encephalitis in a pediatric patient presenting with status dystonicus as the primary clinical manifestation: A case report (CARE)"],"prefix":"10.1097","volume":"104","author":[{"given":"Pingping","family":"Tian","sequence":"first","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wandong","family":"Hu","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufang","family":"Ding","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-7753","authenticated-orcid":false,"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurology Department, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong, China"},{"name":"Neurology Department, Jinan Children\u2019s Hospital, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R2-20251215","first-page":"1020","article-title":"Practical guidelines on the diagnosis and treatment for children with N-methyl-D-aspartate receptor antibody encephalitis (2024).","volume":"62","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/08830738221081593","article-title":"Status dystonicus in children: a cross-sectional study and review of literature.","volume":"37","author":"Saini","year":"2022","journal-title":"J Child Neurol"},{"key":"R4-20251215","first-page":"1148","article-title":"Clinical characteristics of movement disorders in patients with anti-N-methyl-D-aspartate acid receptor encephalitis.","volume":"54","author":"Yan","year":"2021","journal-title":"J Neurol"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.32.10.1195","article-title":"Severe dystonia and myoglobinuria.","volume":"32","author":"Jankovic","year":"1982","journal-title":"Neurology"},{"issue":"Pt 2","key":"R6-20251215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/121.2.243","article-title":"Status dystonicus: the syndrome and its management.","volume":"121","author":"Manji","year":"1998","journal-title":"Brain"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00415-023-11599-0","article-title":"Status dystonicus in adult patients with anti-N-methyl-D-aspartate-acid receptor encephalitis.","volume":"270","author":"Zhang","year":"2023","journal-title":"J Neurol"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/dmcn.12108","article-title":"Dystonia severity action plan: a simple grading system for medical severity of status dystonicus and life-threatening dystonia.","volume":"55","author":"Lumsden","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"105438","DOI":"10.1016\/j.parkreldis.2023.105438","article-title":"The changing face of reported status dystonicus - a systematic review.","volume":"112","author":"Lumsden","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mds.27207","article-title":"Rethinking status dystonicus.","volume":"32","author":"Ruiz-Lopez","year":"2017","journal-title":"Mov Disord"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/archdischild-2023-326814","article-title":"Fifteen-minute consultation: management of acute dystonia exacerbation and status dystonicus.","volume":"110","author":"Lumsden","year":"2025","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.24981","article-title":"Status dystonicus: predictors of outcome and progression patterns of underlying disease.","volume":"27","author":"Fasano","year":"2012","journal-title":"Mov Disord"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MOP.0000000000000556","article-title":"Status dystonicus in childhood.","volume":"29","author":"Lumsden","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/dmcn.14425","article-title":"Prestatus and status dystonicus in children and adolescents.","volume":"62","author":"Garone","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"R15-20251215","first-page":"207","article-title":"Status dystonicus: management and prevention in children at high risk.","volume":"90","author":"Iodice","year":"2019","journal-title":"Acta Biomed"},{"key":"R16-20251215","first-page":"951","article-title":"Progress in diagnosis and treatment of status dystonicus in children.","volume":"35","author":"Lifang","year":"2020","journal-title":"Chin J Pract Pediatr"},{"key":"R17-20251215","first-page":"868","article-title":"Chinese expert consensus on the treatment of dystonia.","volume":"53","year":"2020","journal-title":"J Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:55Z","timestamp":1765814455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":17,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046361","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}